Association Between Markers of Fatty Liver Disease and Impaired Glucose Regulation in Men and Women from the General Population: the KORA-F4-study

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2011 Aug 19

PMID 21850244

Citations 36

Authors

Ina-Maria Ruckert

Margit Heier

Wolfgang Rathmann

Sebastian E Baumeister

Angela Doring

Christa Meisinger

Affiliations

Soon will be listed here.

Abstract

Objective: To investigate whether the elevated liver enzymes gamma-glutamyltransferase (GGT), glutamate-pyruvate transaminase (GPT), glutamate-oxalacetate transaminase (GOT) and alkaline phosphatase (AP) and non-alcoholic fatty liver disease (NAFLD) respectively are independently associated with pre-diabetic states, namely impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) or known and newly diagnosed diabetes (NDD), in men and women from the general German population.

Methods: The study was based on 3009 subjects (1556 females, 1453 males) aged 32 to 81 years who participated in the KORA-F4-Study in 2006/2008 in Augsburg, Southern Germany. All non-diabetic participants underwent an oral glucose tolerance test to assess disturbances in glucose metabolism. NAFLD was estimated by liver enzyme concentrations and the Bedogni Fatty Liver Index (FLI).

Results: 229 participants (7.6%) reported known diabetes, 106 had NDD (3.5%), 107 (3.6%) had IFG, 309 (10.3%) had IGT, 69 (2.3%) were affected with both metabolic disorders (IFG/IGT) and 74 (2.5%) could not be classified. GGT and GPT were significantly elevated in persons with pre-diabetes and diabetes (GGT in diabetic persons OR = 1.76, [1.47-2.09], in IFG OR = 1.79 [1.50-2.13], GPT in diabetic persons OR = 1.51, [1.30-1.74], in NDD OR = 1.77 [1.52-2.06]), GOT and AP only inconsistently in some pre-diabetes groups. The effects were sharpened in models using an increase of two or three out of three enzymes as an estimate of fatty liver and especially in models using the FLI. Overall frequency of NAFLD applying the index was 39.8% (women: 27.3% and men: 53.2%). In participants with fatty liver disease, the OR for NDD adjusted for sex and age was 8.48 [5.13-14.00], 6.70 [3.74-12.01] for combined IFG and IGT and 4.78 [3.47-6.59] for known diabetes respectively.

Conclusions: Elevated GGT and GPT-values as well as estimates of fatty liver disease are significantly associated with pre-diabetes and diabetes and thus very useful first indicators of a disturbed glucose metabolism.

Citing Articles

How epigenetics impacts stroke risk and outcomes through DNA methylation: A systematic review.

Gallego-Fabrega C, Cullell N, Fernandez-Cadenas I J Cereb Blood Flow Metab. 2025; :271678X251322032.

PMID: 40012472 PMC: 11866340. DOI: 10.1177/0271678X251322032.

Clusters of longitudinal risk profile trajectories are associated with cardiometabolic diseases: Results from the population-based KORA cohort.

Niedermayer F, Schauberger G, Rathmann W, Klug S, Thorand B, Peters A PLoS One. 2024; 19(3):e0300966.

PMID: 38547172 PMC: 10977748. DOI: 10.1371/journal.pone.0300966.

The association between fatty liver index and onset of diabetes: secondary analysis of a population-based cohort study.

Zhu Y, Hu H, Wu Y, Rao Y, Li Q, Duan X BMC Public Health. 2023; 23(1):679.

PMID: 37041534 PMC: 10091632. DOI: 10.1186/s12889-023-15442-z.

Examining dyslipidaemia, metabolic syndrome and liver enzyme levels in patients with prediabetes and type 2 diabetes in population from Hoveyzeh cohort study: A case-control study in Iran.

Dinarvand N, Cheraghian B, Rahimi Z, Salehipour Bavarsad S, Bavarsad A, Mohammadtaghvaei N Endocrinol Diabetes Metab. 2023; 6(2):e401.

PMID: 36597273 PMC: 10000631. DOI: 10.1002/edm2.401.

Body surface scan anthropometrics are related to cardiorespiratory fitness in the general population.

Kohler A, Filges B, Volzke H, Felix S, Ewert R, Stubbe B Sci Rep. 2022; 12(1):22185.

PMID: 36564547 PMC: 9789061. DOI: 10.1038/s41598-022-26740-8.

References

Yun J, Cho Y, Park J, Kim H, Park D, Sohn C . Abnormal glucose tolerance in young male patients with nonalcoholic fatty liver disease. Liver Int. 2009; 29(4):525-9. PMC: 2711255. DOI: 10.1111/j.1478-3231.2008.01920.x. View

Schumann G, Bonora R, Ceriotti F, Ferard G, Ferrero C, Franck P . IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. International Federation of Clinical Chemistry and Laboratory Medicine. Part 4. Reference procedure for the measurement of.... Clin Chem Lab Med. 2002; 40(7):718-24. DOI: 10.1515/CCLM.2002.124. View

Schumann G, Bonora R, Ceriotti F, Ferard G, Ferrero C, Franck P . IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. International Federation of Clinical Chemistry and Laboratory Medicine. Part 5. Reference procedure for the measurement of.... Clin Chem Lab Med. 2002; 40(7):725-33. DOI: 10.1515/CCLM.2002.125. View

Hanley A, Williams K, Festa A, Wagenknecht L, DAgostino Jr R, Kempf J . Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes. 2004; 53(10):2623-32. DOI: 10.2337/diabetes.53.10.2623. View

Utzschneider K, Kahn S . Review: The role of insulin resistance in nonalcoholic fatty liver disease. J Clin Endocrinol Metab. 2006; 91(12):4753-61. DOI: 10.1210/jc.2006-0587. View

Nannipieri M, Gonzales C, Baldi S, Posadas R, Williams K, Haffner S . Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study. Diabetes Care. 2005; 28(7):1757-62. DOI: 10.2337/diacare.28.7.1757. View

Rathmann W, Haastert B, Icks A, Lowel H, Meisinger C, Holle R . High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000. Diabetologia. 2003; 46(2):182-9. DOI: 10.1007/s00125-002-1025-0. View

Manco M, Alisi A, Nobili V . Risk of severe liver disease in NAFLD with normal ALT levels: a pediatric report. Hepatology. 2008; 48(6):2087-8. DOI: 10.1002/hep.22631. View

Shin J, Chang S, Shin Y, Seo K, Chung C . Elevated serum gamma-glutamyltransferase levels are independently associated with insulin resistance in non-diabetic subjects. Diabetes Res Clin Pract. 2009; 84(2):152-7. DOI: 10.1016/j.diabres.2009.02.004. View

10.

Speliotes E, Massaro J, Hoffmann U, Vasan R, Meigs J, Sahani D . Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology. 2010; 51(6):1979-87. PMC: 3023160. DOI: 10.1002/hep.23593. View

11.

Fraser A, Ebrahim S, Davey Smith G, Lawlor D . A comparison of associations of alanine aminotransferase and gamma-glutamyltransferase with fasting glucose, fasting insulin, and glycated hemoglobin in women with and without diabetes. Hepatology. 2007; 46(1):158-65. DOI: 10.1002/hep.21667. View

12.

Messier V, Karelis A, Robillard M, Bellefeuille P, Brochu M, Lavoie J . Metabolically healthy but obese individuals: relationship with hepatic enzymes. Metabolism. 2009; 59(1):20-4. DOI: 10.1016/j.metabol.2009.06.020. View

13.

Alberti K, Zimmet P . Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998; 15(7):539-53. DOI: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S. View

14.

Giannini E, Testa R, Savarino V . Liver enzyme alteration: a guide for clinicians. CMAJ. 2005; 172(3):367-79. PMC: 545762. DOI: 10.1503/cmaj.1040752. View

15.

Alisi A, Manco M, Panera N, Nobili V . Association between type two diabetes and non-alcoholic fatty liver disease in youth. Ann Hepatol. 2009; 8 Suppl 1:S44-50. View

16.

Tiniakos D, Vos M, Brunt E . Nonalcoholic fatty liver disease: pathology and pathogenesis. Annu Rev Pathol. 2010; 5:145-71. DOI: 10.1146/annurev-pathol-121808-102132. View

17.

Bellentani S, Marino M . Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD). Ann Hepatol. 2009; 8 Suppl 1:S4-8. View

18.

BERGMEYER H, Horder M, Rej R . International Federation of Clinical Chemistry (IFCC) Scientific Committee, Analytical Section: approved recommendation (1985) on IFCC methods for the measurement of catalytic concentration of enzymes. Part 3. IFCC method for alanine.... J Clin Chem Clin Biochem. 1986; 24(7):481-95. View

19.

BERGMEYER H, Horder M, Rej R . International Federation of Clinical Chemistry (IFCC) Scientific Committee, Analytical Section: approved recommendation (1985) on IFCC methods for the measurement of catalytic concentration of enzymes. Part 2. IFCC method for aspartate.... J Clin Chem Clin Biochem. 1986; 24(7):497-510. View

20.

Vozarova B, Stefan N, Lindsay R, Saremi A, Pratley R, Bogardus C . High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes. 2002; 51(6):1889-95. DOI: 10.2337/diabetes.51.6.1889. View